Flortaucipir F-18 Patent Expiration
Flortaucipir F-18 was first introduced by Avid Radiopharmaceuticals Inc
Flortaucipir F-18 Patents
Given below is the list of patents protecting Flortaucipir F-18, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Tauvid | US8932557 | Imaging agents for detecting neurological dysfunction | May 26, 2032 | Avid Radiopharms Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Flortaucipir F-18's patents.
Latest Legal Activities on Flortaucipir F-18's Patents
Given below is the list recent legal activities going on the following patents of Flortaucipir F-18.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Patent Term Extension Certificate Critical | 18 Oct, 2023 | US8932557 |
Notice of Final Determination -Eligible | 01 Sep, 2023 | US8932557 |
FDA Final Eligibility Letter Critical | 26 Apr, 2023 | US8932557 |
transaction for FDA Determination of Regulatory Review Period | 30 Jun, 2022 | US8932557 |
Payment of Maintenance Fee, 8th Year, Large Entity | 22 Jun, 2022 | US8932557 |
Second letter to regulating agency to determine regulatory review period | 05 Nov, 2021 | US8932557 |
Letter from FDA or Dept of Agriculture re PTE application | 14 Dec, 2020 | US8932557 |
Initial letter Re: PTE Application to regulating agency | 05 Nov, 2020 | US8932557 |
Patent Term Extension Application under 35 USC 156 Filed | 28 Aug, 2020 | US8932557 |
Patent Term Extension Application under 35 USC 156 Filed | 16 Jul, 2020 | US8932557 |